Developer docs
API playgroundTry for free, no card

Search company profiles

Trommsdorff

Full company profile

uuid002adit

Namestring
Trommsdorff
Legal namestring
Trommsdorff GmbH & Co. KG
Websiteurl
trommsdorff.de
Company typeenum
Private
Founded yearint
1790
Descriptiontext

Trommsdorff GmbH & Co. KG is a German pharmaceutical manufacturer founded in 1790 in Erfurt and now headquartered in Alsdorf, Germany. The company develops, manufactures, and distributes prescription pharmaceuticals, over-the-counter medications, food supplements, complementary balanced diets, and medical devices. Its core branded products include Keltican forte (a peripheral nerve regeneration supplement featuring proprietary two-colored UMP-B pellets with vitamin B12, folic acid, UMP, and additional B vitamins), Tromcardin complex (electrolyte and vitamin B1 supplement for heart function), Zodin (omega-3 based blood lipid-lowering product with EPA and DHA from fish oil), and Ozym (high-dose pancreatic enzyme supplement for chronic pancreatic insufficiency). The company also offers contract manufacturing (Lohnfertigung) services to national and international pharmaceutical clients and holds proprietary mini-tablet technology for large active ingredient doses. All production is conducted in GMP-compliant facilities.

Trommsdorff distributes its products primarily through German pharmacies and supplements this channel with direct B2B sales for contract manufacturing. The company employs approximately 120 staff including temporary agency workers, and is a wholly-owned subsidiary of the publicly listed Dermapharm AG since January 1, 2018. Prior ownership was held by the Ferrer Group following integration in 1975. Revenue derives from a mix of branded consumer health products, prescription pharmaceuticals, and contract manufacturing services. The company targets patient segments in cardiology, neurology, respiratory medicine, and more recently urinary tract infections, with both healthcare professional and consumer marketing channels.

Short descriptiontext

Trommsdorff GmbH & Co. KG is a German pharmaceutical manufacturer, founded 1790 and based in Alsdorf, producing branded Rx/OTC drugs, food supplements, and medical devices, plus contract manufacturing services. A wholly-owned Dermapharm AG subsidiary serving cardiology, neurology, respiratory, and urology patients via pharmacy and B2B channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAlsdorf, Germany
HQ citystring
Alsdorf
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, contract manufacturing services, food supplements production, cardiology neurology therapeutics, galenical development
Industry2 codes
PRIMARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Pharmaceutical Products
TypeOne Time License
Description

Manufacturing and distribution of prescription and over-the-counter pharmaceutical products including cardiovascular, neurological, and respiratory medications.

trommsdorff.dermapharm.com
2Food Supplements
TypeOne Time License
Description

Production and sale of food supplements including vitamin combinations and nutritional products such as Tromcardin complex.

trommsdorff.dermapharm.com
3Medical Devices
TypeOne Time License
Description

Distribution of medical devices complementing the pharmaceutical product portfolio.

trommsdorff.dermapharm.com
4Supplementary Balanced Diets
TypeOne Time License
Description

Production and distribution of supplementary balanced diets for specific nutritional requirements.

trommsdorff.dermapharm.com
5Contract Manufacturing Services
TypeProfessional Services
Description

Full-service contract manufacturing (Lohnfertigung) for national and international pharmaceutical customers.

trommsdorff.dermapharm.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Keltican forte
Description

Nerve regeneration supplement with vitamin B12, folic acid, uridine monophosphate (UMP), and vitamins B1, B3, B6 and D3 for peripheral nerve regeneration.

trommsdorff.dermapharm.com
+3 more records
Core offering1 text field

Trommsdorff manufactures and distributes prescription pharmaceuticals, over-the-counter medications, food supplements, supplementary balanced diets, and medical devices from its GMP-compliant facility in Alsdorf, Germany. The company also provides full-service contract manufacturing (Lohnfertigung), galenical development, marketing, and distribution services to national and international pharmaceutical customers. Its core branded portfolio spans cardiovascular, neurological, respiratory, gastrointestinal, and urology therapies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Trommsdorff is a pharmaceutical company offering a portfolio of prescription and non-prescription products including branded medications, nutritional supplements, complementary balanced diets, and medical devices. The core non-prescription products are Keltican® forte (nerve regeneration supplement with UMP-B pellets), Tromcardin® complex (cardiovascular supplement with electrolytes and vitamin B1), Zodin® (omega-3 blood lipid lowering product), and Ozym (pancreatic enzyme supplement). Prescription products cover cardiovascular/cardiology, neurology, and respiratory therapies. The company also recently introduced an innovative product for urinary tract infections. As a Full-Service company, Trommsdorff offers comprehensive manufacturing, contract production (Lohnfertigung), marketing, and distribution services.

Product and service8 records
1Keltican forte
CategoryNon-prescription food supplement (Nahrungsergänzungsmittel)
Description

Nerve regeneration supplement (Nahrungsergänzungsmittel) featuring unique two-color UMP-B pellets with vitamin B12, folic acid, uridine monophosphate (UMP) plus vitamins B1, B3, B6 and D3, targeted at patients needing peripheral nerve regeneration support and nervous system function.

2Tromcardin complex
CategoryNon-prescription food supplement (Nahrungsergänzungsmittel)
Description

Heart function food supplement (Nahrungsergänzungsmittel) combining electrolytes with vitamin B1, lactose-free, gluten-free, and vegan, intended for patients seeking cardiovascular and heart rhythm support.

3Zodin
CategoryNon-prescription pharmaceutical (Arzneimittel)
Description

Non-prescription Arzneimittel containing high-dose EPA and DHA omega-3 fatty acids from fish oil for effective lowering of blood lipids in the therapy of lipid metabolism disorders.

4Ozym
CategoryPrescription pharmaceutical (Arzneimittel)
Description

Prescription high-dose pancreatic enzyme product (Arzneimittel) indicated for chronic pancreatic insufficiency, taken as a complement to every meal.

5Prescription pharmaceuticals portfolio
CategoryPrescription pharmaceuticals
Description

Portfolio of prescription-only medications spanning cardiovascular/cardiology, neurology, and respiratory indications in both children and adults.

6Urinary tract infection product
CategoryNon-prescription pharmaceutical (Arzneimittel)
Description

Innovative non-prescription Arzneimittel recently introduced by Trommsdorff for the treatment of urinary tract infections.

7Medical devices
CategoryMedical devices (Medizinprodukte)
Description

Medical devices (Medizinprodukte) distributed by Trommsdorff as part of the broader product portfolio.

8Contract manufacturing (Lohnfertigung)
CategoryContract manufacturing services
Description

Full-service contract manufacturing service offering galenical development, production, marketing, and sales support to national and international pharmaceutical customers from GMP-compliant facilities in Alsdorf, Germany.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Trommsdorff became a company of the Dermapharm group on January 1, 2018. This ownership provides access to international markets, synergy effects within the Dermapharm network, and enhanced capabilities for innovation, growth, and efficiency. The partnership strengthens Trommsdorff's position to meet globalized market requirements.

2Laboratorios Ferrer S.L.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1975-01-01
Description

Partnership with Laboratorios Ferrer S.L. in Barcelona was pivotal for Trommsdorff's development and led to full integration into the Ferrer Group in 1975. This collaboration shaped the company's product portfolio including cardiovascular, neurological, and respiratory therapies.

trommsdorff.dermapharm.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Strathmann GmbH & Co. KG
TypeDirect peer
Description

Sister company within the Dermapharm Gruppe producing branded Rx and OTC pharmaceuticals. Most directly comparable peer given shared ownership, similar German mid-market manufacturing footprint, and overlapping distribution through German pharmacies.

TypeBroad incumbent
Description

Larger German-headquartered CDMO and pharmaceutical manufacturer serving multiple international pharma customers. Relevant comparator for Trommsdorff's contract manufacturing (Lohnfertigung) business, though Aenova operates at meaningfully greater scale and breadth as a broad industry incumbent.

3Biologische Heilmittel Heel
TypeDirect peer
Description

German pharmaceutical manufacturer producing branded natural and conventional medicines with international reach. Comparable as a German pharma manufacturer with a similar branded product orientation and multi-therapeutic portfolio including neurology and pain indications.

TypeDirect peer
Description

Another Dermapharm Gruppe sister company manufacturing branded generics and OTC pharmaceuticals in Germany. Direct comparator given identical parent ownership, similar German manufacturing base, and parallel pharmacy-channel distribution model.

5Steigerwald Arzneimittelwerk
TypeDirect peer
Description

German pharmaceutical manufacturer of plant-based and branded Rx medicines. Comparable in its German mid-sized pharma profile, branded product orientation, and focus on specific therapeutic niches such as gastroenterology and neurology.

TypeDirect peer
Description

German pharmaceutical manufacturer of similar mid-market size focused on branded Rx products in respiratory and pain therapy. Comparable in its German mid-sized pharma manufacturing profile, branded product focus, and pharmacy-driven distribution.

7Hevert Arzneimittel
TypeDirect peer
Description

Independent German pharmaceutical company of comparable mid-market size producing branded Rx and OTC medicines as well as food supplements. Comparable in its broad-therapeutic branded product strategy and family-owned/independent operating history, mirroring Trommsdorff's full-service model.

TypeDirect peer
Description

German pharmaceutical company with a similar mid-market scale, producing branded Rx and consumer health products. Comparable as a German mid-sized pharma manufacturer with multi-therapeutic product portfolio and pharmacy channel distribution.

TypeDirect peer
Description

German family-owned manufacturer of branded food supplements, medicinal teas, and pharmaceutical products. Comparable in its German mid-sized manufacturing footprint and complementary positioning in food supplements and natural health products.

TypeDirect peer
Description

German mid-sized pharmaceutical manufacturer with a similar profile of branded Rx and OTC products in cardiology, neurology, and metabolic therapy areas. Both companies operate as full-service German pharma manufacturers with multi-therapeutic portfolios distributed through pharmacy channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Trommsdorff

Pharmaceutical Manufacturingtrommsdorff.de

Trommsdorff GmbH & Co. KG is a German pharmaceutical manufacturer, founded 1790 and based in Alsdorf, producing branded Rx/OTC drugs, food supplements, and medical devices, plus contract manufacturing services. A wholly-owned Dermapharm AG subsidiary serving cardiology, neurology, respiratory, and urology patients via pharmacy and B2B channels.

What Trommsdorff does

Trommsdorff GmbH & Co. KG is a German pharmaceutical manufacturer founded in 1790 in Erfurt and now headquartered in Alsdorf, Germany. The company develops, manufactures, and distributes prescription pharmaceuticals, over-the-counter medications, food supplements, complementary balanced diets, and medical devices. Its core branded products include Keltican forte (a peripheral nerve regeneration supplement featuring proprietary two-colored UMP-B pellets with vitamin B12, folic acid, UMP, and additional B vitamins), Tromcardin complex (electrolyte and vitamin B1 supplement for heart function), Zodin (omega-3 based blood lipid-lowering product with EPA and DHA from fish oil), and Ozym (high-dose pancreatic enzyme supplement for chronic pancreatic insufficiency). The company also offers contract manufacturing (Lohnfertigung) services to national and international pharmaceutical clients and holds proprietary mini-tablet technology for large active ingredient doses. All production is conducted in GMP-compliant facilities.

Trommsdorff distributes its products primarily through German pharmacies and supplements this channel with direct B2B sales for contract manufacturing. The company employs approximately 120 staff including temporary agency workers, and is a wholly-owned subsidiary of the publicly listed Dermapharm AG since January 1, 2018. Prior ownership was held by the Ferrer Group following integration in 1975. Revenue derives from a mix of branded consumer health products, prescription pharmaceuticals, and contract manufacturing services. The company targets patient segments in cardiology, neurology, respiratory medicine, and more recently urinary tract infections, with both healthcare professional and consumer marketing channels.

Trommsdorff firmographics

Firmographics
Name
Trommsdorff
Legal name
Trommsdorff GmbH & Co. KG
Website
https://trommsdorff.de
Company type
Private
Founded year
1790
Operating status
Operating
Headcount range
11–50 employees
Short description
Trommsdorff GmbH & Co. KG is a German pharmaceutical manufacturer, founded 1790 and based in Alsdorf, producing branded Rx/OTC drugs, food supplements, and medical devices, plus contract manufacturing services. A wholly-owned Dermapharm AG subsidiary serving cardiology, neurology, respiratory, and urology patients via pharmacy and B2B channels.
Ownership category
akta.pro rank

Trommsdorff industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)

Keywords

  • Pharmaceutical manufacturing
  • Contract manufacturing services
  • Food supplements production
  • Cardiology neurology therapeutics
  • Galenical development

Where Trommsdorff is headquartered

Location

Headquarters

HQ city
Alsdorf
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Trommsdorff business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Products: Manufacturing and distribution of prescription and over-the-counter pharmaceutical products including cardiovascular, neurological, and respiratory medications.
  2. Food Supplements: Production and sale of food supplements including vitamin combinations and nutritional products such as Tromcardin complex.
  3. Medical Devices: Distribution of medical devices complementing the pharmaceutical product portfolio.
  4. Supplementary Balanced Diets: Production and distribution of supplementary balanced diets for specific nutritional requirements.
  5. Contract Manufacturing Services: Full-service contract manufacturing (Lohnfertigung) for national and international pharmaceutical customers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Trommsdorff product offering

Product offering

Core offering

Trommsdorff manufactures and distributes prescription pharmaceuticals, over-the-counter medications, food supplements, supplementary balanced diets, and medical devices from its GMP-compliant facility in Alsdorf, Germany. The company also provides full-service contract manufacturing (Lohnfertigung), galenical development, marketing, and distribution services to national and international pharmaceutical customers. Its core branded portfolio spans cardiovascular, neurological, respiratory, gastrointestinal, and urology therapies.

Product overview

Trommsdorff is a pharmaceutical company offering a portfolio of prescription and non-prescription products including branded medications, nutritional supplements, complementary balanced diets, and medical devices. The core non-prescription products are Keltican® forte (nerve regeneration supplement with UMP-B pellets), Tromcardin® complex (cardiovascular supplement with electrolytes and vitamin B1), Zodin® (omega-3 blood lipid lowering product), and Ozym (pancreatic enzyme supplement). Prescription products cover cardiovascular/cardiology, neurology, and respiratory therapies. The company also recently introduced an innovative product for urinary tract infections. As a Full-Service company, Trommsdorff offers comprehensive manufacturing, contract production (Lohnfertigung), marketing, and distribution services.

Differentiator

Problem solved

Functional benefit

Brands

  • Keltican forte: Nerve regeneration supplement with vitamin B12, folic acid, uridine monophosphate (UMP), and vitamins B1, B3, B6 and D3 for peripheral nerve regeneration.
  • Tromcardin complex
  • Zodin
  • Ozym

Products and services

  • Keltican forte Nerve regeneration supplement (Nahrungsergänzungsmittel) featuring unique two-color UMP-B pellets with vitamin B12, folic acid, uridine monophosphate (UMP) plus vitamins B1, B3, B6 and D3, targeted at patients needing peripheral nerve regeneration support and nervous system function.
  • Tromcardin complex Heart function food supplement (Nahrungsergänzungsmittel) combining electrolytes with vitamin B1, lactose-free, gluten-free, and vegan, intended for patients seeking cardiovascular and heart rhythm support.
  • Zodin Non-prescription Arzneimittel containing high-dose EPA and DHA omega-3 fatty acids from fish oil for effective lowering of blood lipids in the therapy of lipid metabolism disorders.
  • Ozym Prescription high-dose pancreatic enzyme product (Arzneimittel) indicated for chronic pancreatic insufficiency, taken as a complement to every meal.
  • Prescription pharmaceuticals portfolio Portfolio of prescription-only medications spanning cardiovascular/cardiology, neurology, and respiratory indications in both children and adults.
  • Urinary tract infection product Innovative non-prescription Arzneimittel recently introduced by Trommsdorff for the treatment of urinary tract infections.
  • Medical devices Medical devices (Medizinprodukte) distributed by Trommsdorff as part of the broader product portfolio.
  • Contract manufacturing (Lohnfertigung) Full-service contract manufacturing service offering galenical development, production, marketing, and sales support to national and international pharmaceutical customers from GMP-compliant facilities in Alsdorf, Germany.

Companies that use Trommsdorff

Customer profile

Segments4 records

Ideal customer profiles2 records

Trommsdorff technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Trommsdorff partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Dermapharm AGcoreStrategic or Co-development Partner · 1 January 2018Trommsdorff became a company of the Dermapharm group on January 1, 2018. This ownership provides access to international markets, synergy effects within the Dermapharm network, and enhanced capabilities for innovation, growth, and efficiency. The partnership strengthens Trommsdorff's position to meet globalized market requirements.
  • Laboratorios Ferrer S.L.coreStrategic or Co-development Partner · 1 January 1975Partnership with Laboratorios Ferrer S.L. in Barcelona was pivotal for Trommsdorff's development and led to full integration into the Ferrer Group in 1975. This collaboration shaped the company's product portfolio including cardiovascular, neurological, and respiratory therapies.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Trommsdorff competitors and assessment

Company assessment

Direct peers

  • Strathmann GmbH & Co. KG: Sister company within the Dermapharm Gruppe producing branded Rx and OTC pharmaceuticals. Most directly comparable peer given shared ownership, similar German mid-market manufacturing footprint, and overlapping distribution through German pharmacies.
  • Biologische Heilmittel Heel: German pharmaceutical manufacturer producing branded natural and conventional medicines with international reach. Comparable as a German pharma manufacturer with a similar branded product orientation and multi-therapeutic portfolio including neurology and pain indications.
  • mibe Arzneimittel: Another Dermapharm Gruppe sister company manufacturing branded generics and OTC pharmaceuticals in Germany. Direct comparator given identical parent ownership, similar German manufacturing base, and parallel pharmacy-channel distribution model.
  • Steigerwald Arzneimittelwerk: German pharmaceutical manufacturer of plant-based and branded Rx medicines. Comparable in its German mid-sized pharma profile, branded product orientation, and focus on specific therapeutic niches such as gastroenterology and neurology.
  • Krewel Meuselbach: German pharmaceutical manufacturer of similar mid-market size focused on branded Rx products in respiratory and pain therapy. Comparable in its German mid-sized pharma manufacturing profile, branded product focus, and pharmacy-driven distribution.
  • Hevert Arzneimittel: Independent German pharmaceutical company of comparable mid-market size producing branded Rx and OTC medicines as well as food supplements. Comparable in its broad-therapeutic branded product strategy and family-owned/independent operating history, mirroring Trommsdorff's full-service model.
  • Hermes Arzneimittel: German pharmaceutical company with a similar mid-market scale, producing branded Rx and consumer health products. Comparable as a German mid-sized pharma manufacturer with multi-therapeutic product portfolio and pharmacy channel distribution.
  • Salus Group: German family-owned manufacturer of branded food supplements, medicinal teas, and pharmaceutical products. Comparable in its German mid-sized manufacturing footprint and complementary positioning in food supplements and natural health products.
  • Wörwag Pharma: German mid-sized pharmaceutical manufacturer with a similar profile of branded Rx and OTC products in cardiology, neurology, and metabolic therapy areas. Both companies operate as full-service German pharma manufacturers with multi-therapeutic portfolios distributed through pharmacy channels.

Broad incumbents

  • Aenova Group: Larger German-headquartered CDMO and pharmaceutical manufacturer serving multiple international pharma customers. Relevant comparator for Trommsdorff's contract manufacturing (Lohnfertigung) business, though Aenova operates at meaningfully greater scale and breadth as a broad industry incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Trommsdorff financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Trommsdorff leadership team

Management profile

Number of profiles

Trommsdorff funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Trommsdorff M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trommsdorff

What does Trommsdorff do?

Trommsdorff manufactures and distributes prescription pharmaceuticals, over-the-counter medications, food supplements, supplementary balanced diets, and medical devices from its GMP-compliant facility in Alsdorf, Germany. The company also provides full-service contract manufacturing (Lohnfertigung), galenical development, marketing, and distribution services to national and international pharmaceutical customers. Its core branded portfolio spans cardiovascular, neurological, respiratory, gastrointestinal, and urology therapies.

Is Trommsdorff a public or private company?

Trommsdorff is a private company. It is classified as corporate owned and is currently operating.

When was Trommsdorff founded?

Trommsdorff was founded in 1790. It employs 11 to 50 people.

Where is Trommsdorff based?

Trommsdorff is headquartered in Alsdorf, Germany, in the Europe region.

How does Trommsdorff make money?

Five revenue lines are on record. Pharmaceutical Products are the primary driver. The others are food Supplements, medical Devices, supplementary Balanced Diets and contract Manufacturing Services.

Who are Trommsdorff's main competitors?

Direct peers on record are Strathmann GmbH & Co. KG, Biologische Heilmittel Heel, mibe Arzneimittel, Steigerwald Arzneimittelwerk, Krewel Meuselbach, Hevert Arzneimittel, Hermes Arzneimittel, Salus Group and Wörwag Pharma. Aenova Group is listed as a broad incumbent.

Does Trommsdorff have an API?

No public API is recorded for Trommsdorff.

What industry is Trommsdorff in?

Trommsdorff's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity), with a secondary code of HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales